Literature DB >> 14501603

Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen.

Sally E Shaywitz1, Frederick Naftolin, Daniel Zelterman, Karen E Marchione, John M Holahan, Steven F Palter, Bennett A Shaywitz.   

Abstract

OBJECTIVE: Considerable controversy surrounds the issue of whether estrogen influences cognitive function in postmenopausal women, and the results are far from consistent. For the most part, the cognitive processes studied have involved memory; to our knowledge, no previous studies have specifically examined the effects of estrogen on women's reading ability.
DESIGN: To investigate reading and short-term memory in postmenopausal women treated with conjugated equine estrogens, we carried out a randomized, double-blind, placebo-controlled trial of 21 days in 60 midlife, postmenopausal women aged 32.8 to 64.9 years (mean 51.2 years, SD 5.0 years). Women were evaluated for oral reading measured by Gray Oral Reading Tests (third edition) and for verbal memory using immediate and delayed recall on the Logical Memory and Paired Associate Learning subtests of the Wechsler Memory Scale and by a Sentence Span task.
RESULTS: The group receiving daily treatment with conjugated equine estrogens (Premarin, 1.25 mg; Wyeth-Ayerst Labs, Philadelphia, PA, USA) showed better oral reading and verbal memory performance than the placebo group.
CONCLUSION: Estrogen may have positive effects on oral reading and verbal memory in midlife, postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14501603     DOI: 10.1097/01.GME.0000060241.02837.29

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  29 in total

1.  Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.

Authors:  Paul A Newhouse; Julie Dumas; Heather Wilkins; Emily Coderre; Cynthia K Sites; Magdalena Naylor; Chawki Benkelfat; Simon N Young
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

Review 2.  Effects of hormone therapy on cognition and mood.

Authors:  Barbara Fischer; Carey Gleason; Sanjay Asthana
Journal:  Fertil Steril       Date:  2014-04       Impact factor: 7.329

Review 3.  The Women's Health Initiative study: perspectives and implications for clinical practice.

Authors:  Charles B Hammond
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

Review 4.  Hormone therapy and cognitive function.

Authors:  Pauline M Maki; Erin Sundermann
Journal:  Hum Reprod Update       Date:  2009-05-25       Impact factor: 15.610

Review 5.  Estrogen-cholinergic interactions: Implications for cognitive aging.

Authors:  Paul Newhouse; Julie Dumas
Journal:  Horm Behav       Date:  2015-07-14       Impact factor: 3.587

6.  Influence of estradiol on functional brain organization for working memory.

Authors:  Jane E Joseph; Joshua E Swearingen; Christine R Corbly; Thomas E Curry; Thomas H Kelly
Journal:  Neuroimage       Date:  2011-10-01       Impact factor: 6.556

7.  Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.

Authors:  Yiwei Wang; Gerson Hernandez; Wendy J Mack; Lon S Schneider; Fei Yin; Roberta D Brinton
Journal:  Menopause       Date:  2020-01       Impact factor: 2.953

Review 8.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

9.  A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics.

Authors:  Mary Sano; Diane Jacobs; Howard Andrews; Karen Bell; Neill Graff-Radford; John Lucas; Peter Rabins; Karen Bolla; Wei-Yan Tsai; Peter Cross; Karen Andrews; Rosann Costa
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

Review 10.  Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies.

Authors:  Pauline M Maki
Journal:  Menopause       Date:  2013-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.